R

R&G PharmaStudies Co Ltd
SZSE:301333

Watchlist Manager
R&G PharmaStudies Co Ltd
SZSE:301333
Watchlist
Price: 72.08 CNY -5.15% Market Closed
Market Cap: 7B CNY

Intrinsic Value

The intrinsic value of one R&G PharmaStudies Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 72.08 CNY, R&G PharmaStudies Co Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

R&G PharmaStudies Co Ltd Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
R&G PharmaStudies Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

R&G PharmaStudies Co Ltd looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether R&G PharmaStudies Co Ltd usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about R&G PharmaStudies Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is R&G PharmaStudies Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for R&G PharmaStudies Co Ltd.

Explain Valuation
Compare R&G PharmaStudies Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about R&G PharmaStudies Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
R&G PharmaStudies Co Ltd

Current Assets 2.1B
Cash & Short-Term Investments 1.7B
Receivables 311.2m
Other Current Assets 76m
Non-Current Assets 201.7m
Long-Term Investments 33m
PP&E 53.8m
Intangibles 103.6m
Other Non-Current Assets 11.3m
Current Liabilities 382.1m
Accounts Payable 42m
Accrued Liabilities 51.7m
Short-Term Debt 173.3k
Other Current Liabilities 288.2m
Non-Current Liabilities 40.4m
Long-Term Debt 31.5m
Other Non-Current Liabilities 8.8m
Efficiency

Free Cash Flow Analysis
R&G PharmaStudies Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
R&G PharmaStudies Co Ltd

Revenue
789.4m CNY
Cost of Revenue
-521m CNY
Gross Profit
268.4m CNY
Operating Expenses
-126.2m CNY
Operating Income
142.2m CNY
Other Expenses
9.2m CNY
Net Income
151.4m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

R&G PharmaStudies Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Positive ROIC
Healthy Operating Margin
Healthy Gross Margin
hidden
Profitability
Score

R&G PharmaStudies Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

R&G PharmaStudies Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
hidden
Solvency
Score

R&G PharmaStudies Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
R&G PharmaStudies Co Ltd

Wall Street analysts forecast R&G PharmaStudies Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for R&G PharmaStudies Co Ltd is 67.83 CNY with a low forecast of 67.17 CNY and a high forecast of 69.83 CNY.

Lowest
Price Target
67.17 CNY
7% Downside
Average
Price Target
67.83 CNY
6% Downside
Highest
Price Target
69.83 CNY
3% Downside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for R&G PharmaStudies Co Ltd is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one R&G PharmaStudies Co Ltd stock?

The intrinsic value of one R&G PharmaStudies Co Ltd stock under the Base Case scenario is hidden CNY.

Is R&G PharmaStudies Co Ltd stock undervalued or overvalued?

Compared to the current market price of 72.08 CNY, R&G PharmaStudies Co Ltd is hidden .

Back to Top